Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Netherlands Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20033
20041
20065
20072
20083
20093
20102
20117
20126
20135
20142
20157
20161
20173
20185
201910
20203
20215
20225
20232
20245
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Terminated19
Active, not recruiting12
Recruiting8
Unknown status4
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals11
European Organisation for Research and Treatment of Cancer - EORTC9
Maastricht Radiation Oncology7
Eli Lilly and Company6
The Netherlands Cancer Institute6
ETOP IBCSG Partners Foundation5
Hoffmann-La Roche5
Bristol-Myers Squibb4
Daiichi Sankyo4
GlaxoSmithKline4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung100
Lung Neoplasms19
Neoplasm Metastasis8
Neoplasms6
Melanoma5
Adenocarcinoma of Lung4
Pancreatic Neoplasms4
Brain Neoplasms3
Carcinoma, Renal Cell3
Head and Neck Neoplasms3

Trials

Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.